Cybin Corp updates investors on its IP development
Articles
North America Psychedelic Drugs Market Could Exceed $6.8 Billion By 2027
PALM BEACH, Fla., Jan. 6, 2021 /PRNewswire/ -- In the few places where cannabis is legal, it can be incredibly lucrative. In 2019, the nascent worldwide cannabis sector pumped out approximately $15 billion in sales.
Colorado Governor Requests $5M To Support Marijuana Entrepreneurs And Social Equity Businesses
Colorado’s governor is looking to further assist the marijuana industry and entrepreneurs from communities most impacted by the drug war through a proposed program to provide businesses a pool of resources that they are currently ineligible for.
From USciences to Argentina and beyond, the son of filmmaker Errol Morris explores psychedelics for VICE TV
While the world waited breathlessly this fall for anything resembling definitive results from the Nov. 3 presidential election, one early winner seemed clear: drugs.
Minnesota Moves Closer to Cannabis Legalization
Minnesota is still pushing for legalization and planning to try again during this legislative session, although they are still facing some resistance from the state Senate.
New Psychedelics ETF Is Another Sector Milestone
The new Horizons Psychedelic Stock Index ETF will add new demand and increased visibility for psychedelic drug stocks.
Cannabis Sales Surpass $1B In Illinois
Combined adult-use and medical cannabis sales topped $1 billion in Illinois, with recreational sales nearing $670 million and medical sales reaching $331 million. Adult-use sales launched in the state on Jan. 1, 2020.
Oregon Voters Said Yes To Using Psilocybin As A Mental Health Therapy. What’s Next?
During the November election, Oregon voters approved a measure allowing licensed centers to provide psilocybin, the substance found in “magic mushrooms,” to help treat people experiencing a range of mental health issues.
Veterinarians Can Consult On Marijuana And CBD Therapy For Pets Under Michigan Governor-Signed Bill
The governor of Michigan has signed a bill that allows veterinarians to consult with pet owners about the therapeutic use of marijuana and hemp-derived products such as CBD.
Minerco Inc The Magic Mushroom Company Signs LOI with Jamaican Firm Lazurus Holistic to Grow, Process and Extract Psilocybin and Cannabis for Export to Canada and Europe
Oakland, California--(Newsfile Corp. - January 4, 2021) - OTC:MINE signs a Joint Venture letter of intent with Lazurus Holistic to serve as psilocybin experts to grow and develop a unique strain of mushrooms specific to Jamaica.
Four Top Psychedelic Stock Picks for 2021
ATLANTA, Jan. 04, 2021 (GLOBE NEWSWIRE) -- 2020 was a banner year for investors in psychedelic companies as investors in Mind Medicine (MindMed) Inc. (OTCQB: MMEDF), 20/20 Global, Inc. (OTC: TWGL), Compass Pathways (NASDAQ: CMPS), and Numinus Wellness Inc. (OTC: LKYSF) saw their money triple and even quadruple.
Might a safer version of a psychedelic help treat depression?
Research in animals suggests that the new compound is neither toxic nor hallucinogenic and that it may help treat a range of psychiatric disorders, including depression and addiction, and possibly anxiety and post-traumatic stress disorder (PTSD).
New Mexico Judge Rules Inmates Have A Right To Medical Cannabis
A state district judge in New Mexico has ruled that inmates and parolees have a right to use medical marijuana and that correctional institutions must provide access to cannabis to qualified patients, even if they are behind bars.
Best Music Playlists For Psychedelic Therapy Are Explored In New Johns Hopkins Study
Psychedelic therapy sessions often incorporate music—and typically that music is of the classical genre.
Entheon Biomedical Announces Investment and Business Arrangement with Heading Health LLC
Vancouver, British Columbia--(Newsfile Corp. - January 4, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) ("Entheon" or the "Company"), a biotechnology company focused on developing psychedelic medicines to treat addiction, is announcing a business arrangement with, and a strategic investment in, Heading Health, LLC ("Heading Health"), a psychiatric clinic platform focused on the administration of psychedelic-assisted therapy to treat mental health disorders.